A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

A three‐lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy

Abstract Background Current strategies are insufficient to predict pathologically complete response (pCR) for esophageal squamous cell carcinomas (ESCCs) before treatment. Here, we aim to develop a novel long noncoding RNA (lncRNA) signature for pCR and outcome prediction of ESCCs through a multicen...

Full description

Bibliographic Details
Main Authors: Chaoqi Zhang, Zhihui Zhang, Guochao Zhang, Liyan Xue, Haijun Yang, Yuejun Luo, Xiaoli Zheng, Yonglei Zhang, Yufen Yuan, Ruixue Lei, Zhaoyang Yang, Bo Zheng, Zhen Zhang, Le Wang, Yun Che, Sihui Wang, Feng Wang, Lingling Fang, Qingpeng Zeng, Jiagen Li, Shugeng Gao, Qi Xue, Nan Sun, Jie He
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Clinical and Translational Medicine
Subjects:
esophageal squamous cell carcinoma
lncRNAs
neoadjuvant chemoradiotherapy
pathologically complete response
individualized medicine
Online Access:https://doi.org/10.1002/ctm2.156

Internet

https://doi.org/10.1002/ctm2.156

Similar Items